Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT
Fate Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.91M | 1.63M | 1.86M | 3.07M | 6.77M | 1.93M | 1.68M | 1.94M | 933K | 58.98M | 44.36M | 14.98M | 18.55M | 18.41M | 17.07M | 14.22M | 13.41M | 11.14M |
Cost of Revenue | 3.28M | n/a | n/a | 4.61M | 4.72M | 4.82M | 4.88M | 4.74M | 4.47M | 4.19M | 4.84M | 3.19M | 81.31M | 72.14M | 69.52M | 53.13M | 48.02M | 44.85M |
Gross Profit | -1.37M | 1.63M | 1.86M | 3.07M | 2.05M | -2.9M | -3.21M | -2.8M | -3.53M | 54.79M | 39.51M | 11.79M | -62.76M | -53.73M | -52.45M | -38.91M | -34.61M | -33.71M |
Operating Income | -36.97M | -41.28M | -61.75M | -52.38M | -45.08M | -51.07M | -48.08M | -51.28M | -62.56M | -28.59M | -64.42M | -86.39M | -83.11M | -74.47M | -69.38M | -54.62M | -46.78M | -46.21M |
Interest Income | 2.92M | 3.34M | 3.87M | 4.44M | 4.83M | 4.15M | 4.41M | 4.7M | 4.38M | 3.69M | 2.88M | 1.79M | 757K | 418K | 297K | 289K | 346K | 377K |
Pretax Income | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -18.88M | -56.36M | -83.56M | -76.11M | -65.69M | -68.62M | -43.31M | -55.13M | -45.09M |
Net Income | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -9.17M | -48.31M | -80.73M | -76.11M | -56.91M | -68.62M | -43.31M | -55.13M | -45.09M |
Selling & General & Admin | 11.45M | 13.77M | 15.26M | 20.8M | 17.25M | 20.86M | 17.93M | 18.95M | 22.62M | 21.94M | 21.58M | 21.55M | 20.35M | 20.74M | 16.93M | 15.72M | 12.17M | 12.5M |
Research & Development | 27.43M | 29.14M | 33.61M | 34.65M | 34.6M | 32.14M | 31.82M | 34.27M | 40.88M | 65.63M | 87.19M | 79.82M | 81.31M | 72.14M | 69.51M | 53.13M | 48.02M | 44.85M |
Other Expenses | n/a | n/a | 14.74M | n/a | -4.72M | -4.82M | -4.88M | -4.74M | n/a | n/a | 5.18M | 1.04M | 6.25M | 8.36M | n/a | n/a | n/a | n/a |
Operating Expenses | 38.88M | 42.91M | 63.61M | 55.45M | 47.13M | 48.17M | 44.87M | 48.48M | 63.5M | 87.57M | 108.78M | 101.37M | 101.66M | 92.88M | 86.45M | 68.85M | 60.19M | 57.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.88M | 42.91M | 63.61M | 55.45M | 51.85M | 52.99M | 49.75M | 53.22M | 63.5M | 87.57M | 108.78M | 101.37M | 101.66M | 92.88M | 86.45M | 68.85M | 60.19M | 57.35M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.71M | -8.06M | -2.83M | n/a | -8.78M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
Shares Outstanding (Diluted) | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
EPS (Basic) | -0.29 | -0.32 | -0.44 | -0.4 | -0.33 | -0.47 | -0.45 | -0.46 | -0.54 | -0.09 | -0.5 | -0.83 | -0.79 | -0.59 | -0.72 | -0.45 | -0.58 | -0.48 |
EPS (Diluted) | -0.29 | -0.32 | -0.44 | -0.4 | -0.33 | -0.47 | -0.45 | -0.46 | -0.54 | -0.09 | -0.5 | -0.83 | -0.79 | -0.59 | -0.72 | -0.45 | -0.58 | -0.48 |
EBITDA | -36.97M | -37.95M | -42.2M | -47.77M | -40.36M | -46.25M | -43.19M | -46.54M | -58.1M | -24.4M | -59.58M | -83.2M | -80.15M | -71.71M | -66.42M | -53.1M | -45.61M | -45.25M |
EBIT | -34.07M | -41.28M | -47.01M | -52.38M | -45.08M | -51.07M | -48.08M | -51.28M | -62.56M | -28.59M | -64.42M | -86.39M | -83.11M | -74.47M | -68.62M | -54.62M | -46.78M | -46.21M |
Depreciation & Amortization | 3.28M | 3.33M | 4.81M | 4.61M | 4.72M | 4.82M | 4.88M | 4.74M | 4.47M | 4.19M | 4.84M | 3.19M | 2.96M | 2.76M | 2.21M | 1.52M | 1.17M | 959K |